Skip to main content

Peer Review reports

From: Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol

Original Submission
23 Oct 2018 Submitted Original manuscript
30 Nov 2018 Author responded Author comments - Masatoshi Takagi
Resubmission - Version 2
30 Nov 2018 Submitted Manuscript version 2
Publishing
18 Jan 2019 Editorially accepted
26 Jan 2019 Article published 10.1186/s12887-019-1409-7

You can find further information about peer review here.

Back to article page